Quantitative natural history characterization in a cohort of 142 published cases of patients with galactosialidosis-A cross-sectional study.
Adolescent
Adult
Biomarkers
Child
Child, Preschool
Cohort Studies
Cross-Sectional Studies
Delayed Diagnosis
Drug Development
Female
Humans
Infant
Infant, Newborn
Lysosomal Storage Diseases
/ diagnosis
Male
Middle Aged
Mutation
Phenotype
Radiography
Review Literature as Topic
Survival Analysis
Young Adult
drug development
galactosialidosis
orphan disease
radiological findings
survival
Journal
Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
29
06
2018
revised:
01
09
2018
accepted:
18
09
2018
pubmed:
30
1
2019
medline:
19
6
2020
entrez:
30
1
2019
Statut:
ppublish
Résumé
Galactosialidosis (GS; OMIM #256540) is a rare multisystemic inborn glycoprotein storage disease caused by biallelic mutations in the cathepsin A gene resulting in combined deficiency of the lysosomal enzymes β-galactosidase and α-neuraminidase. The precise understanding of the natural course of the disease is limited. Development of enzyme replacement therapy is at the preclinical stage. The purpose of this research project was to quantitatively characterize the natural history of the condition. Quantitative analysis of all published cases in the literature with sufficient data (N = 142 patients) was carried out. Main outcome variables were survival, diagnostic delay, description of symptoms, biomarker-phenotype associations, and radiological findings. STROBE criteria were respected. Median survival age of the cohort was 48 years. Median age of onset was 4.25 years with interquartile range (IQR) 1 to 16 years. Median age at diagnosis was 19 (IQR: 8.92-29) years, with median diagnostic delay of 8 (IQR: 4-12) years. Patients with residual β-galactosidase activity of more than 8.6% (leukocytes) survived significantly longer than patients with lower enzyme activities.
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
295-302Informations de copyright
© 2018 SSIEM.